Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04673877 · ClinicalTrials.gov registry record · Phase 1
Vancomycin Tissue Concentrations by Bier Block or Intravenous Administration
A Phase 1 study of Infection and Hand Injuries, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT04673877: Completed Phase 1 study of Infection and Hand Injuries, sponsored by Mayo Clinic.
NCT04673877 is a Phase 1 study of Infection and Hand Injuries that has completed, run by Mayo Clinic. The registered enrollment target is 20 participants, below the 726-participant average among 41 other Infection trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04673877, a Phase 1 study of Infection and Hand Injuries, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether or not giving a lower dose of antibiotics (Vancomycin) in the area where it is needed (upper extremity) is more effective at preventing infection than the current standard dose which is given intravenously (IV).
Primary Outcome
Tissue concentrations of vancomycin in the hand and wrist following Bier Block administration versus systemic IV administration
Conditions Studied
Interventions
- DRUG Vancomycin
- DRUG Systemic IV Vancomycin
- PROCEDURE Bier Block
Study Locations (1)
Arizona
- Mayo Clinic in Arizona - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-08-26 |
| Est. Completion | 2022-08-17 |
| Phase | Phase 1 |
What the finished NCT04673877 record still lists
NCT04673877 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 726-participant average among 41 other Infection trials with a reported enrollment target (97% lower).
The record links to 5 conditions, with Infection appearing as the primary indexed condition, and to 3 interventions - of which Vancomycin is the first listed.
NCT04673877 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT04673877 about?
NCT04673877 is a clinical study titled "Vancomycin Tissue Concentrations by Bier Block or Intravenous Administration". The purpose of this study is to determine whether or not giving a lower dose of antibiotics (Vancomycin) in the area where it is needed (upper extremity) is more effective at preventing infection than the current standard dose which is given intravenously (IV).
What is the current status of trial NCT04673877?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2021-08-26. Estimated completion is 2022-08-17.
What conditions does trial NCT04673877 study?
This clinical trial studies the following conditions: Infection, Hand Injuries, Hand Arthritis, Hand Injury Wrist, Hand Injuries and Disorders.
What interventions are being tested in trial NCT04673877?
The interventions under investigation include: Vancomycin (DRUG), Systemic IV Vancomycin (DRUG), Bier Block (PROCEDURE).
Who is sponsoring clinical trial NCT04673877?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04673877 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04673877's enrollment target sits among peer trials
20 38th of 41 higher than 4 of 41 other Infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)
RECRUITING · Phase 1
-
Pharmacokinetics and Safety of Cefazolin 2g in DUPLEX
COMPLETED · Phase 1
-
Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation
COMPLETED · Phase 1
-
Triple Dye Plus Alcohol Versus Triple Dye Alone for Newborn Umbilical Cord Care
COMPLETED · Phase 1
-
Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma
COMPLETED · Phase 1
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI